| Outgoing Relation(s) |
| NF-κB inhibitor (CHEBI:73240) is a inhibitor (CHEBI:35222) |
| Incoming Relation(s) |
| (+)-conocarpan (CHEBI:69251) has role NF-κB inhibitor (CHEBI:73240) |
| (S)-glaucine (CHEBI:5373) has role NF-κB inhibitor (CHEBI:73240) |
| (−)-larreatricin (CHEBI:69246) has role NF-κB inhibitor (CHEBI:73240) |
| (2S,3S)-2,3-dihydro-3-hydroxymethyl-2-(4-hydroxyphenyl)-5-(E)-propenylbenzofuran (CHEBI:69248) has role NF-κB inhibitor (CHEBI:73240) |
| meso-3,3'-didemethoxynectandrin B (CHEBI:69247) has role NF-κB inhibitor (CHEBI:73240) |
| 1-O-caffeoylquinic acid (CHEBI:136555) has role NF-κB inhibitor (CHEBI:73240) |
| 1'-acetoxychavicol acetate (CHEBI:469) has role NF-κB inhibitor (CHEBI:73240) |
| 15-O-desmethyl-(5Z)-7-oxozeaenol (CHEBI:67555) has role NF-κB inhibitor (CHEBI:73240) |
| 2-(2-hydroxy-4-methoxyphenyl)-5-(3-hydroxypropyl)benzofuran (CHEBI:69249) has role NF-κB inhibitor (CHEBI:73240) |
| 2-(2,4-dihydroxyphenyl)-5-(E)-propenylbenzofuran (CHEBI:69250) has role NF-κB inhibitor (CHEBI:73240) |
| 2-(4-hydroxyphenyl)-5-(E)-propenylbenzofuran (CHEBI:69252) has role NF-κB inhibitor (CHEBI:73240) |
| 5-(3-hydroxypropyl)-2-(2-methoxy-4-hydroxyphenyl)benzofuran (CHEBI:69245) has role NF-κB inhibitor (CHEBI:73240) |
| 5E-7-oxozeaenol (CHEBI:67558) has role NF-κB inhibitor (CHEBI:73240) |
| 5Z-7-oxozeaenol (CHEBI:67559) has role NF-κB inhibitor (CHEBI:73240) |
| 7-epi-zeaenol (CHEBI:67557) has role NF-κB inhibitor (CHEBI:73240) |
| aconine (CHEBI:132639) has role NF-κB inhibitor (CHEBI:73240) |
| ammonium pyrrolidinedithiocarbamate (CHEBI:234321) has role NF-κB inhibitor (CHEBI:73240) |
| BAY11-7085 (CHEBI:176500) has role NF-κB inhibitor (CHEBI:73240) |
| brazilin (CHEBI:3170) has role NF-κB inhibitor (CHEBI:73240) |
| CBL0137 (CHEBI:138650) has role NF-κB inhibitor (CHEBI:73240) |
| cochinchinone A (CHEBI:65646) has role NF-κB inhibitor (CHEBI:73240) |
| disulfiram (CHEBI:4659) has role NF-κB inhibitor (CHEBI:73240) |
| ergolide (CHEBI:69340) has role NF-κB inhibitor (CHEBI:73240) |
| eugenol (CHEBI:4917) has role NF-κB inhibitor (CHEBI:73240) |
| EVP4593 (CHEBI:232358) has role NF-κB inhibitor (CHEBI:73240) |
| IKK16 (CHEBI:92257) has role NF-κB inhibitor (CHEBI:73240) |
| JSH-23 (CHEBI:131326) has role NF-κB inhibitor (CHEBI:73240) |
| kojic acid (CHEBI:43572) has role NF-κB inhibitor (CHEBI:73240) |
| NF-κB Activation Inhibitor IV (CHEBI:233280) has role NF-κB inhibitor (CHEBI:73240) |
| oleuropein (CHEBI:7747) has role NF-κB inhibitor (CHEBI:73240) |
| orbiculin A (CHEBI:66824) has role NF-κB inhibitor (CHEBI:73240) |
| orbiculin D (CHEBI:66825) has role NF-κB inhibitor (CHEBI:73240) |
| orbiculin E (CHEBI:66826) has role NF-κB inhibitor (CHEBI:73240) |
| orbiculin F (CHEBI:66827) has role NF-κB inhibitor (CHEBI:73240) |
| orbiculin G (CHEBI:66828) has role NF-κB inhibitor (CHEBI:73240) |
| orbiculin H (CHEBI:66829) has role NF-κB inhibitor (CHEBI:73240) |
| orbiculin I (CHEBI:66830) has role NF-κB inhibitor (CHEBI:73240) |
| piperine (CHEBI:28821) has role NF-κB inhibitor (CHEBI:73240) |
| pyrrolidine dithiocarbamate (CHEBI:78782) has role NF-κB inhibitor (CHEBI:73240) |
| rataniaphenol I (CHEBI:69254) has role NF-κB inhibitor (CHEBI:73240) |
| rataniaphenol II (CHEBI:69255) has role NF-κB inhibitor (CHEBI:73240) |
| rataniaphenol III (CHEBI:69253) has role NF-κB inhibitor (CHEBI:73240) |
| rubimaillin (CHEBI:141063) has role NF-κB inhibitor (CHEBI:73240) |
| SC75741 (CHEBI:232877) has role NF-κB inhibitor (CHEBI:73240) |
| SN50 (CHEBI:195371) has role NF-κB inhibitor (CHEBI:73240) |
| talosin A (CHEBI:66186) has role NF-κB inhibitor (CHEBI:73240) |
| tubocapsanolide A (CHEBI:66325) has role NF-κB inhibitor (CHEBI:73240) |
| zeaenol (CHEBI:67556) has role NF-κB inhibitor (CHEBI:73240) |
| β-(4-hydroxyphenyl)ethyl-4-O-E-caffeoyl-O-[β-D-apiofuranosyl-(1→2)]-β-D-glucopyranoside (CHEBI:68340) has role NF-κB inhibitor (CHEBI:73240) |
| δ-tocotrienol (CHEBI:33276) has role NF-κB inhibitor (CHEBI:73240) |
